These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3319474)

  • 1. Drugs that promote renal excretion of riboflavin.
    Pinto JT; Rivlin RS
    Drug Nutr Interact; 1987; 5(3):143-51. PubMed ID: 3319474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary riboflavin excretion resulting from boric acid ingestion.
    Pinto J; Huang YP; McConnell RJ; Rivlin RS
    J Lab Clin Med; 1978 Jul; 92(1):126-34. PubMed ID: 659962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated development of riboflavin deficiency by treatment with chlorpromazine.
    Pelliccione N; Pinto J; Huang YP; Rivlin RS
    Biochem Pharmacol; 1983 Oct; 32(19):2949-53. PubMed ID: 6626265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline.
    Pinto J; Huang YP; Rivlin RS
    J Clin Invest; 1981 May; 67(5):1500-6. PubMed ID: 6262379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of riboflavin in female patients with liver cirrhosis.
    Zempleni J; Galloway JR; McCormick DB
    Int J Vitam Nutr Res; 1996; 66(3):237-43. PubMed ID: 8899458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional effects of oral contraceptive use: a review.
    Webb JL
    J Reprod Med; 1980 Oct; 25(4):150-6. PubMed ID: 7001015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of vitamins B1 and B2 during phenylketonuria].
    Kodentsova VM; Vrzhesinskaia OA; Denisova SN; Spirichev VB
    Vopr Med Khim; 1999; 45(2):150-7. PubMed ID: 10378305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of vitamin B2 status of organism by means of twenty-four hour riboflavin urinary excretion].
    Vrzhecinskaia OA; Kodentsova VM
    Vopr Pitan; 2008; 77(2):40-3. PubMed ID: 18505098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary riboflavin and its metabolites: effects of riboflavin supplementation in healthy residents of rural Georgia (USA).
    Roughead ZK; McCormick DB
    Eur J Clin Nutr; 1991 Jun; 45(6):299-307. PubMed ID: 1915203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between riboflavin intake and excretion in female rats after weaning of the litter.
    Leclerc J; Miller ML
    Int J Vitam Nutr Res; 1987; 57(1):45-51. PubMed ID: 3583594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in vitamin status of Indian Antarctic expeditioners during a one-month stay in Austral Summer.
    Vats P; Singh SN; Singh VK; Shyam R; Upadhyay TN; Singh SB; Banerjee PK
    Wilderness Environ Med; 2007; 18(4):258-63. PubMed ID: 18076290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity.
    Bidlack WR; Brown RC; Mohan C
    Fed Proc; 1986 Feb; 45(2):142-8. PubMed ID: 3510912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.